{
    "root": "34679342-bf84-f9e4-e063-6294a90aae55",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "INDOMETHACIN",
    "value": "20250505",
    "ingredients": [
        {
            "name": "SUCROSE",
            "code": "C151H8M554"
        },
        {
            "name": "TALC",
            "code": "7SEV7J4R1U"
        },
        {
            "name": "TITANIUM DIOXIDE",
            "code": "15FIX9V2JP"
        },
        {
            "name": "STARCH, CORN",
            "code": "O8232NY3SJ"
        },
        {
            "name": "D&C YELLOW NO. 10",
            "code": "35SW5USQ3G"
        },
        {
            "name": "GELATIN",
            "code": "2G86QN327L"
        },
        {
            "name": "MANNITOL",
            "code": "3OWL53L36A"
        },
        {
            "name": "POVIDONE",
            "code": "FZ989GH94E"
        },
        {
            "name": "INDOMETHACIN",
            "code": "XXE1CET956"
        }
    ],
    "indications": "indomethacin extended-release capsules indicated : moderate severe rheumatoid arthritis including acute flares chronic disease moderate severe ankylosing spondylitis moderate severe osteoarthritis acute painful shoulder ( bursitis and/or tendinitis )",
    "contraindications": "lowest effective shortest duration consistent individual patient treatment goals ( 2.1 ) moderate severe rheumatoid arthritis including acute flares chronic disease ; moderate severe ankylosing spondylitis ; moderate severe osteoarthritis one indomethacin extended-release 75 mg capsule daily ( 2.2 ) acute painful shoulder ( bursitis and/or tendinitis ) one indomethacin extended-release 75 mg capsule twice daily ( 2.3 )",
    "warningsAndPrecautions": "indomethacin extended-release capsules , 75 mg , supplied yellow opaque cap natural body black imprint “ k 16 ” cap body , filled white pellets . bottles 10 capsules , ndc 55289-469-10 storage store room temperature 20°c 25°c ( 68°f 77°f ) ; excursions permitted 15°c 30°c ( 59°f 86°f ) [ usp controlled room temperature ] . protect moisture .",
    "adverseReactions": "indomethacin extended-release capsules contraindicated following patients : known hypersensitivity ( e.g . , anaphylactic serious skin ) indomethacin components product [ ( 5.7 , 5.9 ) ] history asthma , urticaria , allergic-type taking aspirin nsaids . severe , sometimes fatal , anaphylactic nsaids reported patients [ ( 5.7 , 5.8 ) ] setting coronary artery bypass graft ( cabg ) surgery [ ( 5.1 ) ]",
    "indications_original": "Indomethacin extended-release capsules are indicated for:\n                  \n                  \n                     Moderate to severe rheumatoid arthritis including acute flares of chronic disease\n                     Moderate to severe ankylosing spondylitis\n                     Moderate to severe osteoarthritis\n                     Acute painful shoulder (bursitis and/or tendinitis)",
    "contraindications_original": "Use the lowest effective dosage for shortest duration consistent with individual patient treatment goals ( 2.1 ) The dosage for moderate to severe rheumatoid arthritis including acute flares of chronic disease; moderate to severe ankylosing spondylitis; and moderate to severe osteoarthritis is one indomethacin extended-release 75 mg capsule daily ( 2.2 ) The dosage for acute painful shoulder (bursitis and/or tendinitis) is one indomethacin extended-release 75 mg capsule once or twice daily ( 2.3 )",
    "warningsAndPrecautions_original": "Indomethacin extended-release capsules, 75 mg each, are supplied as yellow opaque cap and natural body with black imprint “K 16” on both cap and body, filled with white pellets.\n                  Bottles of 10 capsules, NDC 55289-469-10\n                  \n                  Storage\n                  Store at room temperature 20°C to 25°C (68°F to 77°F); with excursions permitted between 15°C to 30°C (59°F to 86°F) [see USP Controlled Room Temperature]. Protect from moisture.",
    "adverseReactions_original": "Indomethacin extended-release capsules are contraindicated in the following patients:\n                  \n                     Known hypersensitivity (e.g., anaphylactic reactions and serious skin reactions) to indomethacin or any components of the drug product [\n  \n   see Warnings and Precautions (\n   \n    5.7, \n   \n    5.9)\n  \n   ]\n \n  \n                     History of asthma, urticaria, or other allergic-type reactions after taking aspirin or other NSAIDs. Severe, sometimes fatal, anaphylactic reactions to NSAIDs have been reported in such patients [\n  \n   see Warnings and Precautions (\n   \n    5.7, \n   \n    5.8)\n  \n   ]\n \n  \n                     In the setting of coronary artery bypass graft (CABG) surgery [\n  \n   see Warnings and Precautions (\n   \n    5.1)\n  \n   ]"
}